SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-124474
Filing Date
2020-04-29
Accepted
2020-04-29 07:32:03
Documents
5
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A d923408ddefa14a.htm DEFA14A 19171
2 GRAPHIC g923408na1.jpg GRAPHIC 129298
3 GRAPHIC g923408na2.jpg GRAPHIC 179991
4 GRAPHIC g923408na3.jpg GRAPHIC 60455
5 GRAPHIC g923408na4.jpg GRAPHIC 15419
  Complete submission text file 0001193125-20-124474.txt   511845
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36544 | Film No.: 20827394
SIC: 2834 Pharmaceutical Preparations